Immune Cell Metabolic Analysis Higher-Sensitivity XF Analysis Solution
Agilent Technologies introduced the Agilent Seahorse XF HS Miniplate designed specifically for the Seahorse XF HS Mini Analyzer for improved immune cell metabolic analysis.
Enhanced data quality, easier workflow, and more versatile analytics using fewer cell numbers — this is how Agilent sums up the advantages of the new Seahorse XF HS Miniplate.
Immunology and disease researchers are increasingly using rare, ex vivo, and genetically engineered cells to build better disease models. Limitations in the quantities of these cells that they can produce, however, restrict these researchers in the types of cellular assays they can perform.
The XF HS Mini is the latest addition to Agilent’s range of Seahorse XF platforms, which analyze mitochondrial respiration, glycolysis, and ATP production in live cells, in real-time. These metabolic measurements enable researchers to better understand cell health, function, and signaling.
The highly sensitive XF HS Mini analyzer offers improved performance and precision, requiring fewer cells per well, an improved more consistent suspension cell workflow, and streamlined analytics. These improvements enable researchers to confidently generate XF data from quantity limited or low respiring cell types, such as immune cells, where measurements were previously not possible.